| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8791098 | American Journal of Ophthalmology Case Reports | 2018 | 4 Pages |
Abstract
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections are a valuable treatment option for reversing neovascularization in eyes with proliferative diabetic retinopathy with fewer side effects when compared to standard pan-retinal photocoagulation. Additionally, we also illustrate restoration of retinal perfusion post anti-VEGF therapy indicative of pre-existingsalvageableischemic retina tissue.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Shruti Chandra, Jay Sheth, Giridhar Anantharaman, Mahesh Gopalakrishnan,